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ABSTRACT
Background: Severe traumatic brain injury (TBI) is associ-
ated with a high mortality rate and those that survive
commonly have permanent disability. While there is a
broad consensus that appropriate prehospital treatment is
crucial for a favorable neurological outcome, evidence to
support currently applied treatment strategies is scarce. In
particular, the relationship between prehospital treatments
and patient outcomes is unclear. The BRAIN-PROTECT
study therefore aims to identify prehospital treatment
strategies associated with beneficial or detrimental out-
comes. Here, we present the study protocol. Study
Protocol: BRAIN-PROTECT is the acronym for BRAin
INjury: Prehospital Registry of Outcome, Treatments and
Epidemiology of Cerebral Trauma. It is a prospective
observational study on the prehospital treatment of
patients with suspected severe TBI in the Netherlands.
Prehospital epidemiology, interventions, medication strat-
egies, and nonmedical factors that may affect outcome are
studied. Multivariable regression based modeling will be
used to identify confounder-adjusted relationships
between these factors and patient outcomes, including
mortality at 30 days (primary outcome) or mortality and
functional neurological outcome at 1 year (secondary out-
comes). Patients in whom severe TBI is suspected during
prehospital treatment (Glasgow Coma Scale score  8 in
combination with a trauma mechanism or clinical findings
suggestive of head injury) are identified by all four heli-
copter emergency medical services (HEMS) in the
Netherlands. Patients are prospectively followed up in 9
participating trauma centers for up to one year. The
manuscript reports in detail the objectives, setting, study
design, patient inclusion, and data collection process.
Ethical and juridical aspects, statistical considerations, as
well as limitations of the study design are discussed.
Discussion: Current prehospital treatment of patients
with suspected severe TBI is based on marginal evidence,
and optimal treatment is basically unknown. The BRAIN-
PROTECT study provides an opportunity to evaluate and
compare different treatment strategies with respect to
patient outcomes. To our knowledge, this study project is
the first large-scale prospective prehospital registry of
patients with severe TBI that also collects long-term fol-
low-up data and may provide the best available evidence
at this time to give useful insights on how prehospital
care can be improved
.List of Abbreviations: AIS: Abreviated Injury Score;
AMC: Amsterdam Medical Center (University hospital,
part of AUMC); ANOVA: Analysis of Variance; AUMC:
Amsterdam University Medical Centers (two main loca-
tions addressed as “VUmc” and “AMC”); CI: Confidence
Interval; CT (scan): Computed Tomography scan; EMS:
Emergency Medical Services; EMV: Eye Motor Verbal
score; Erasmus MC: Erasmus Medical Center (University
hospital); GCS: Glasgow Coma Scale; GLM: Generalized
Linear Models; GOS: Glasgow Outcome Scale; GOSE:
Glasgow Outcome Scale – Extended; HEMS: (Physician-
based) Helicopter Emergency Medical Service; ISS: Injury
Severity Score; PEARL: Pupils Equal And Reacting to
Light; Radboud UMC: University Medical Center
Radboud Nijmegen (University hospital); RTS: Revised
Trauma Score; SSC: Scientific Steering Committee; TBI:
Traumatic Brain Injury; UMCG: University Medical
Center Groningen; UMCU: University medical Center
Utrecht (University hospital); VUMC: VU Medical Center
(University hospital, part of AUMC); WBP: Wet
Bescherming Persoonsgegevens; WMO: Wet Medisch-
wetenschappelijk Onderzoek met mensen Key words:
(MESH): air ambulances; brain injuries; traumatic; clinical
protocols; emergency medical services; treatment outcome
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INTRODUCTION
Severe traumatic brain injury (TBI) is a leading
cause of death and permanent disability in the
population under 45 years and imposes a consider-
able burden on society through loss of productive
life years and lifetime costs of care (1–3). The tre-
mendous impact of TBI on individual patients, as
well as the socioeconomic relevance, necessitates the
development of optimal treatment strategies to
ensure the best possible outcomes.
Prehospital healthcare providers have the unique
opportunity to treat the patient at the earliest pos-
sible moments during the so called “golden hour”
of trauma care, and there is broad consensus that
effective early treatment at this stage can substan-
tially contribute to improved outcomes (4–7). The
aims of prehospital management of patients with
severe TBI are rapid transport to an appropriate
treatment facility, while preventing and treating fac-
tors that are known to trigger secondary brain inju-
ries, such as hypoxia, hypotension, as well as hypo-
and hyperventilation (4, 6). Specific treatments, e.g.,
those aiming at control of intracranial pressure (e.g.,
mannitol) or to limit intracerebral hemorrhage (e.g.,
tranexamic acid), may also be administered in the
prehospital setting (8, 9). However, given a large
spectrum of treatment possibilities and limited evi-
dence for any of those treatments, it is still unclear
how patients should be optimally treated in the
acute or prehospital setting (4, 10–13). Examples of
controversial topics requiring further evidence
include: optimal airway management and ventila-
tion strategies (13, 14), how hemodynamic instability
can best be treated (15), and the use of hyperosmo-
lar drugs to reduce intracranial pressure (16, 17).
Logistic and operational factors, such the mode of
patient transport, distances to trauma centers or pre-
hospital treatment times may also have a relevant
influence on patient outcomes and warrant further
investigation to optimize organizational aspects of
prehospital trauma care.
2 PREHOSPITAL EMERGENCY CARE / 2019 VOLUME 0 / NUMBER 0
International guidelines for the management of
TBI have been published by the Brain Trauma
Foundation, the American Association of
Neurological Surgeons and the Congress of
Neurological Surgeons (18, 19). Remarkably, the
quality of evidence was considered low for all pre-
hospital treatments, and the strength of all recom-
mendations concerning any prehospital therapeutic
intervention, treatment threshold or monitoring
modality was weak (19). The bottom line is that pre-
hospital treatment of severe TBI is currently a black
box in which a spectrum of different treatment
approaches is applied, but in which the effects of
these treatments on outcomes remain unclear.
To address the current knowledge gaps, the
BRAIN-PROTECT research consortium has set itself
the goal to investigate the relationship between the
prehospital treatment of patients with suspected
severe TBI and outcomes. We here present the study
protocol of the BRAIN-PROTECT study.
METHODS
BRAIN-PROTECT Study Objective
BRAIN-PROTECT is the acronym for BRAin
INjury: Prehospital Registry of Outcome,
Treatments and Epidemiology of Cerebral Trauma.
The main objective of this research project is to
identify prehospital factors, in particular treatment
strategies, associated with beneficial or detrimental
outcomes in patients with suspected severe TBI. We
focus on patients with severe TBI, because these
patients are at high risk for impairments of vital
functions and secondary brain injury, and may
profit most from optimal prehospital treatment. We
chose to study patients with suspected — rather
than confirmed — severe TBI because prehospital
treatment is based on the suspicion, not on the final
diagnosis, and we wish to obtain estimates for treat-
ment effects that are relevant to current practice in
the prehospital setting. Nonetheless, the data also
allow subanalyses of patients with confirmed TBI.
Ultimately, the analysis of the collected data is
intended to allow improvements in prehospital
treatment and patient outcomes.
Design and Setting
The BRAIN-PROTECT study is a prospective,
observational study of the prehospital treatment of
patients with suspected severe TBI in The
Netherlands. The Netherlands has a population of
about 17.2 million inhabitants, with an average
population density of 504 persons per square
kilometer (20). Prehospital trauma care is provided
by 25 regional ambulance services. Generally, two
ambulance vehicles, each with a qualified prehospi-
tal emergency medical nurse and a medically
trained ambulance driver, are dispatched to
major accidents.
Additionally, a 24/7 physician-based Helicopter
Emergency Medical Service (HEMS) system is avail-
able in the Netherlands. HEMS physicians are either
anesthesiologists or surgeons, all well trained in pre-
hospital emergency procedures. Other team mem-
bers include a certified flight nurse and a pilot. The
four EC135 helicopters (Airbus Helicopters) of this
HEMS operation are stationed in Amsterdam (call-
sign “Lifeliner 1”), Rotterdam (“Lifeliner 2”),
Nijmegen (“Lifeliner 3”), and Groningen (“Lifeliner
4”) (Figure 1). If required for logistic, technical, or
meteorological reasons, the HEMS team can respond
to accidents using a designated road ambu-
lance vehicle.
The purpose of the HEMS is to complement the
ambulance care by providing specific expertise, not
to substitute ambulance care. Hence, HEMS teams
are dispatched in addition to, rather than instead of,
ground ambulance teams. Based on a catalog of dis-
patch criteria, a HEMS team is routinely activated
for all patients with suspected severe traumatic
brain injury (21). The activation threshold is low,
resulting in overtriage and a substantial proportion
(about 50%) of canceled missions (22). Occasionally,
the trauma severity is initially underestimated by
FIGURE 1. Map of the Netherlands, showing the location of the
participating helicopter emergency medical services (HEMS)
operators and their associated respective trauma centers
(LL1–LL4; i.e., representing 4 HEMS and 4 level 1 trauma
centers), as well as participating trauma centers without HEMS
operation (A–E). See Table 1 for details.
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the dispatch center. In such cases, a HEMS team can
be secondarily activated by the ambulance team at
the accident scene. In the majority of cases of severe
TBI, HEMS teams arrive at the accident scene to
treat the patient. However, if the patient is ready for
transport in the ground ambulance before HEMS
arrival, the ambulance and HEMS will commonly
rendezvous en route to the hospital. Hence, a HEMS
team is involved in the treatment of the vast major-
ity of patients with prehospitally suspected severe
TBI, with only few exceptions (e.g., unavailability of
a HEMS team, scoop-and-run to a nearby hospital).
After initial prehospital treatment and stabiliza-
tion, patients with severe TBI are transported to des-
ignated level 1 trauma centers. Currently, there are
11 officially appointed trauma centers with 24/7
treatment facilities for all severely injured patients,
plus an additional trauma center with level 1 facili-
ties for all adult trauma patients, but without pedi-
atric facilities. Only in exceptional circumstances
(e.g., catastrophic hemorrhage that cannot be con-
trolled), patients are transported to the nearest
regional hospital instead of a designated
trauma center.
Patient Inclusion and Prospective Follow-
up in Participating Centers
All patients with suspected severe TBI treated by
one of the four Dutch HEMS operations are identi-
fied, based on the combination of a trauma with a
prehospital Glasgow Coma Scale (GCS) (23) score 
8 that does not consistently restore above 8 during
the prehospital treatment, in combination with a
trauma mechanism or clinical findings that are sug-
gestive for head injury. Patients who were declared
dead on scene as well as patients with possible
brain injury but in whom traumatic head injury is
not suspected, such as suffocation, drowning, or
strangulation, are not considered for inclusion. No
age restrictions are imposed for inclusion in the
research database.
Identified patients are prospectively followed up
by an independent data manager (see below) in 9
participating trauma centers for in-hospital data and
outcome data until 1 year after the accident. The
type of collected data is described in more detail
below. Data acquisition began in February 2012 with
a phased approach across the participating centers,
and follow up data have been collected until
December 2018. Table 1 and Figure 1 summarize the
participating centers.
Scientific Oversight
A Scientific Steering Committee (SSC) was imple-
mented to oversee the scientific activities during the
study. The SSC is multidisciplinary, containing dele-
gates from the Emergency Medical Services, HEMS,
Neurosurgery, Neurology, Trauma surgery, and
Anesthesiology. Most members of the SSC have an
extensive academic background in (trauma related)
research or a clinical background in the treatment of
patients with TBI. Two members of the group hold
master degrees in medical statistics and epidemi-
ology, respectively, and contribute the respective
methodologic and statistical expertise.
Ethics, Privacy and Legislation
The Medical Research Ethics Boards of the
Amsterdam University Medical Center, location
VUmc (at the time of approval: VU University
Medical Center, reference number 2012/041) and
Erasmus MC Rotterdam (reference number MEC-
2012-515) reviewed the study protocol and con-
cluded that the research is not subject to the Dutch
Medical Research Involving Human Subjects Act
(Wet medisch-wetenschappelijk onderzoek met mensen,
WMO). In this observational study, patients were
not subject to any treatment interventions other
TABLE 1. Participating HEMS and trauma centers
Reference Name Location Start prehospital inclusion
HEMS & Trauma centers LL1 Amsterdam UMC, location VUmc± Amsterdam 02-2012
LL2 Erasmus MC± Rotterdam 04-2014
LL3 Radboud UMC± Nijmegen 11-2012
LL4 UMC Groningen± Groningen 01-2013
Trauma centers A Isala Zwolle
B Medisch Spectrum Twente Enschede
C Elisabeth-TweeSteden Tilburg
D Noordwest ziekenhuisgroep Alkmaar
E UMCU± Utrecht
±University Medical Centers
LL [number] ¼ PHEMS in the Netherlands, referring to the number from which location it is deployed (e.g., Amsterdam, Rotterdam, Nijmegen, or Groningen).
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than standard care, such that informed consent for
treatment is not applicable. Informed consent for the
inclusion of data into the research database and
study participation could not be obtained at the
time of the accident in the comatose patient popula-
tion. As a requirement to obtain secondary informed
consent from patients or relatives could cause sub-
stantial inclusion bias, a leading Dutch law firm spe-
cializing in patient privacy legislation was
consulted. We adopted their suggested approach to
comply with the Dutch Personal Data Protection
Act (Wet Bescherming Persoonsgegevens, WBP), while
waving the requirement for informed consent
according to Dutch law: All patient data were coded
and anonymized by an independent data-manager
(not employed by the researchers, paid by a third
party, not involved in publication of the data). This
allowed us to combine anonymous prehospital,
inhospital, and outcome data in the research data-
base, while ensuring that data could not be traced
back to individual patients by anyone — including
the researchers — except the data-manager. All cod-
ing lists and all personally identifiable information
are securely stored in the respective trauma centers
at all times. Informed consent is, however, required
and obtained for a telephonic interview with the
patient or a proxy at one year after the accident to
obtain the Extended Glasgow Outcomes Scale score.
This interview is conducted by the data-manager,
who is the only person who can link the patient
code in the research database back to the original
patient file in order to obtain contact information.
Prior to the interview, patients or their relatives
receive a letter in which they are informed about
the ongoing study and that they will be approached
for an interview on a voluntary basis.
Data Collection
Data registration is based on the Utstein template
for uniform reporting of data following major
trauma (24, 25), supplemented with other variables
of interest. The following data are collected:
A. Prehospital Data and Suspected Injuries.
Prehospital data are collected by the four HEMS.
These data include the following:
 Operational data (e.g., dispatch times and distances,
type of transport).
 Demographic data (e.g., gender and age)
 Trauma mechanism and observed or sus-
pected injuries.
 Vital parameters, routinely measured at 3 time
points: on arrival at the patient, after initial stabiliza-
tion, and before arrival at the hospital. Relevant vital
parameters measured at other time points (e.g., nadir
values to document hypotension, bradycardia, or
desaturation; or any other measurements deemed
relevant) could also be entered in the database.
 Prehospital interventions (ranging from basic preho-
spital treatments, such as oxygen administration, type
of intravascular access, or use of immobilization
devices, through details of basic and advanced air-
way management and ventilation techniques, to
advanced prehospital management such as diagnostic
ultrasound or thoracostomy).
 Prehospital medications and fluids.
B. Intra-hospital Data and Confirmed Injury
Characteristics.
The data-manager identifies the included patients
in participating trauma centers, based on matches
between prehospital information (e.g., date and time
of arrival at hospital, gender, trauma mechanism
and other characteristic information) and queries
performed in the trauma centers. Subsequently, the
data manager collects follow-up data as well as pre-
vious medical history data. These data include
the following:
 Medical history, including preinjury medication.
 First vital parameters in the emergency department.
 First in-hospital laboratory values.
 First key interventions.
 Cerebral CT imaging results [observed injuries,
Marshall score (26), Rotterdam score (27)].
 Other detected injuries.
 Operations in the first 48 hours.
 Revised Trauma Score (RTS) (28).
 Abbreviated Injury Scale (AIS) scores (until 2014,
the 1995 version, update 1998 was used; as of 2015,
the 2005 version, update 2008 was used across all
trauma centers) (29).
 Injury Severity Score (30).
C. Outcome Data.
Outcome data are also mainly collected in the
trauma centers, and long-term functional outcome
data are obtained by a telephone interview with
patients (or proxies in the case of persisting severe
inabilities) who can be contacted by the data man-
ager and who provide informed consent.
Primary outcome:
 Mortality at 30 days (binary outcome — dead versus
alive at 30 days)
Secondary Outcomes:
 Survival time, mortality at discharge, at 6 months
and at 1 year.
 Length of hospital stay.
 Length of intensive care unit stay.
 Days on mechanical ventilator.
 Any documented complications during hos-
pital admission.
 Glasgow Outcome Scale (GOS) score at dis-
charge (31).
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 Extended Glasgow Outcome Scale (GOSE) score at
1 year (10–14 months) (32).
Statistical Considerations
A. Sample size, Power and Minimum
Detectable Difference
The target for patient recruitment was set at 2500
patients. This sample size provides 80% power for a
two-sided test to detect an absolute 5% reduction in
mortality (primary outcome) for a given treatment
or intervention, at a 0.05 alpha level, assuming a
baseline mortality rate of 30%, and assuming an
equal distribution of patients across two treatment
groups. At this sample size, the expected number of
deaths (625–750, assuming an overall mortality
between 25 and 30%) is sufficient for liberal adjust-
ments for potential confounding variables, without
risking overfitting in multivariable regression analy-
ses. As incomplete follow-up and missing data are
inevitable in an observational study — and, as not
all patients will be eligible for specific analyses (e.g.,
subanalyses on patients with actually confirmed
severe TBI) — the actual minimum detectable
difference can differ from 5%. For example, a
sample size of 2000, 1500, or 1000 patients, respect-
ively, provides 80% power to detect a 5.6%, 6.4% or
7.8% mortality reduction, respectively, and still pro-
vides ample opportunity to control for confounding.
B. Interim Analyses
No interim analyses have been planned a priori.
However, data are regularly inspected and checked
for the purpose of data quality monitoring and data
cleaning, and a limited set of descriptive analyses
are performed to inform collaborators and stake-
holders on the study progress. In addition, medical
students who assist in the entering of anonymized
prehospital data into the database during a scientific
internship are allowed to analyze parts of the data
for their internship reports. Only testing of a-priori
hypotheses, defined at the beginning of each intern-
ship in a formal proposal, are allowed, to avoid
data dredging. None of these preliminary analyses
(performed by the students themselves, therefore
not always conforming to accepted statistical stand-
ards) has been or will be published or otherwise
communicated to the public. Since these analyses
are exclusively for training but not for inferential
purposes, we are not planning to adjust subsequent
inferential analyses for these preliminary analyses.
C. Statistical Analysis Plan
The distribution of continuous data is assessed by
histograms, Q-Q plots, and Shapiro-Wilk tests.
Descriptive statistics for demographic data, injury
characteristics, treatments, as well as outcome data
include means and standard deviations, medians
and quartiles, or numbers and percentages as appro-
priate. Unadjusted two-sided between-group com-
parisons are performed by hypothesis tests such as
Pearson’s chi-square tests, Student’s t-tests or ana-
lysis of variance (ANOVA), for binary and continu-
ous outcomes, respectively. Multivariable regression
models are used to obtain adjusted estimates of
treatment effects of the factor under investigation
(independent variable of main interest) and its stat-
istical significance, while accounting for potential
confounders (additional independent variables in
the model) (33). For this purpose, Generalized
Linear Models (GLM) and their extensions are used,
with appropriate link functions depending on the
distribution of the dependent variable of interest.
For the primary outcome, a logit link function
(logistic regression model) is used (33). Treatment
effect estimates, such as mean differences or odds
ratios, are reported including 95% confidence inter-
vals (34).
DISCUSSION
We aim to implement a nationwide prospective
database, including all patients in whom severe TBI
is suspected in the prehospital setting. Inclusion of
patients via the four national HEMS operators is the
most feasible approach, as compared to inclusion at
25 regional ambulance services. Severe TBI is a pri-
mary deployment criterion for HEMS in the
Netherlands, and so this approach should result in
a high capture rate of patients with severe TBI.
Nonetheless, a minority might be treated by
Ambulance EMS only (e.g., scoop-and-run or
unavailability of HEMS). Moreover, patients who do
not appear severely injured in the prehospital set-
ting may deteriorate in the hospital or turn out to
be more severely injured than initially assumed (35).
Such patients, despite having severe TBI, are not
included using our approach. However, this was a
deliberate choice as the study focusses on the preho-
spital treatment of those patients who are prehospi-
tally assumed to have severe TBI.
Importantly, the research is subject to the inherent
limitations of observational studies. Such studies
generally only permit an analysis of the associations
between factors of interest and outcomes, but do
not support causal inferences. Nonetheless, in the
absence of other high quality prehospital data, the
observed confounder-adjusted associations may gen-
erate hypotheses on the optimal prehospital treat-
ment of patients with suspected severe TBI.
To minimize selection bias, all consecutive
patients who comply with the inclusion criteria are
included. Information bias is minimized by the
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prospective design and use of objective (e.g., blood
pressure) and validated (e.g., AIS scores) data.
However, in a dynamic prehospital setting where
variables are repetitively observed or measured at
varying intervals, standardization of measurement
time points is difficult. In this study, vital parame-
ters were routinely documented at three predeter-
mined time points, with the possibility to add
additional relevant vital parameters at other time
points to document nadir values or vital parameters
associated with specific events or interventions.
However, measurement artifacts, oversight of brief
events (e.g., brief hypotension after induction of
anesthesia), deliberate nonreporting of complica-
tions, or documentation errors cannot be excluded
and may bias the results.
Data cleaning techniques are used to identify
implausible values for all variables in the database,
which are subsequently cross checked against the
original data sources by the data-manager.
Implausible values that cannot be confirmed or cor-
rected are set to missing. In particular, correct
assessment of prehospital GCS scores play a pivotal
role as they are, among other criteria, an inclusion
criterion. HEMS physicians are competent to assess
this score, which has been shown to provide excel-
lent reliability (36). When it is not possible to per-
form an assessment, e.g., after induction of
anesthesia, the relevant scores are routinely
recorded as “not assessible” rather than assigning a
score of 3. Nonetheless, we cannot exclude the pos-
sibility that GCS sores are occasionally inadvertently
scored after sedative medication had been
administered.
Data obtained in a physician-based HEMS envir-
onment in the Dutch setting may not necessarily
readily generalize to paramedic-based systems or to
countries with different demographic, geographic,
or logistic characteristics (37). For all these reasons,
reported results must be interpreted with care and
should be confirmed in further studies.
SUMMARY AND CONCLUSIONS
Current prehospital treatment of patients with
suspected severe TBI is based on marginal evidence,
and optimal treatment is basically unknown. The
BRAIN-PROTECT study provides the unique oppor-
tunity to evaluate and compare different treatment
strategies with respect to patient outcomes. To our
knowledge, this study project is the first large-scale
prospective prehospital registry of patients with
severe TBI that also collects long-term follow-up
data, and may provide the best available evidence
at this time to give useful insights on how prehospi-
tal care can be improved in the future.
ORCID
Sebastiaan M. Bossers http://orcid.org/0000-0002-
2396-2777
Frank W. Bloemers http://orcid.org/0000-0002-
8393-4946
Nico Hoogerwerf http://orcid.org/0000-0003-
1815-6989
References
1. Rutland-Brown W, Langlois JA, Thomas KE, Xi YL.
Incidence of traumatic brain injury in the United States,
2003. J Head Trauma Rehabil. 2006;21(6):544–8. doi:10.1097/
00001199-200611000-00009.
2. Langlois JA, Rutland-Brown W, Wald MM. The epidemi-
ology and impact of traumatic brain injury: a brief overview.
J Head Trauma Rehabil. 2006;21(5):375–8. doi:10.1097/
00001199-200609000-00001.
3. Scholten AC, Haagsma JA, Panneman MJ, van Beeck EF,
Polinder S. Traumatic brain injury in the Netherlands: inci-
dence, costs and disability-adjusted life years. PLoS One.
2014;9(10):e110905. doi:10.1371/journal.pone.0110905.
4. Boer C, Franschman G, Loer SA. Prehospital management of
severe traumatic brain injury: concepts and ongoing contro-
versies. Curr Opin Anaesthesiol. 2012;25(5):556–62. doi:
10.1097/ACO.0b013e328357225c.
5. Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli
A, et al. Traumatic brain injury: integrated approaches to
improve prevention, clinical care, and research. Lancet
Neurol. 2017;16(12):987–1048. doi:10.1016/S1474-
4422(17)30371-X.
6. Hammell CL, Henning JD. Prehospital management of severe
traumatic brain injury. BMJ. 2009;338:b1683. doi:10.1136/
bmj.b1683.
7. Maas AI, Stocchetti N, Bullock R. Moderate and severe trau-
matic brain injury in adults. Lancet Neurol. 2008;7(8):728–41.
doi:10.1016/S1474-4422(08)70164-9.
8. Crash-2 Collaborators IBS. Effect of tranexamic acid in trau-
matic brain injury: a nested randomised, placebo controlled
trial (CRASH-2 Intracranial Bleeding Study). BMJ. 2011;343:
d3795.
9. Sayre MR, Daily SW, Stern SA, Storer DL, van Loveren HR,
Hurst JM. Out-of-hospital administration of mannitol to
head-injured patients does not change systolic blood pres-
sure. Acad Emerg Med. 1996;3(9):840–8. doi:10.1111/j.1553-
2712.1996.tb03528.x.
10. Menon DK. Unique challenges in clinical trials in traumatic
brain injury. Crit Care Med. 2009;37(1 Suppl):S129–S35. doi:
10.1097/CCM.0b013e3181921225.
11. Rosenfeld JV, Maas AI, Bragge P, Morganti-Kossmann MC,
Manley GT, Gruen RL. Early management of severe trau-
matic brain injury. Lancet. 2012;380(9847):1088–98. doi:
10.1016/S0140-6736(12)60864-2.
12. Stocchetti N, Taccone FS, Citerio G, Pepe PE, Le Roux PD,
Oddo M, et al. Neuroprotection in acute brain injury: an up-
to-date review. Critical Care. 2015;19:186. doi:10.1186/s13054-
015-0887-8.
S. M. Bossers et al. THE BRAIN-PROTECT STUDY PROTOCOL 7
13. Bossers SM, Schwarte LA, Loer SA, Twisk JW, Boer C,
Schober P. Experience in prehospital endotracheal intubation
significantly influences mortality of patients with severe
traumatic brain injury: a systematic review and meta-ana-
lysis. PLoS One. 2015;10(10):e0141034. doi:10.1371/
journal.pone.0141034.
14. Roberts BW, Karagiannis P, Coletta M, Kilgannon JH,
Chansky ME, Trzeciak S. Effects of PaCO2 derangements on
clinical outcomes after cerebral injury: a systematic review.
Resuscitation. 2015;91:32–41. doi:10.1016/
j.resuscitation.2015.03.015.
15. Hylands M, Toma A, Beaudoin N, Frenette AJ, D'Aragon F,
Belley-Cote E, et al. Early vasopressor use following trau-
matic injury: a systematic review. BMJ Open. 2017;7(11):
e017559.
16. Wang K, Sun M, Jiang H, Cao XP, Zeng J. Mannitol cannot
reduce the mortality on acute severe traumatic brain injury
(TBI) patients: a meta-analyses and systematic review. Burns
Trauma. 2015;3:8.
17. Berger-Pelleiter E, Emond M, Lauzier F, Shields JF, Turgeon
AF. Hypertonic saline in severe traumatic brain injury: a sys-
tematic review and meta-analysis of randomized controlled
trials. CJEM. 2016;18(2):112–20. doi:10.1017/cem.2016.12.
18. Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW,
Bell MJ, et al. Guidelines for the management of severe trau-
matic brain injury, fourth edition. Neurosurgery. 2017;80(1):
6–15. doi:10.1227/NEU.0000000000001432.
19. Badjatia N, Carney N, Crocco TJ, Fallat ME, Hennes HM,
Jagoda AS, et al. Guidelines for prehospital management of
traumatic brain injury 2nd edition. Prehosp Emerg Care.
2008;12(Suppl 1):S1–52. doi:10.1080/10903120701732052.
20. CBS. 2018. Dutch population density statistics by Central
Bureau for Statistics (CBS). Available at: http://statline.cbs.
nl/Statweb/.
21. Ambulancezorg Nederland, Landelijk Netwerk Acute Zorg.
MMT Inzet- en Cancelcriteria. 2013.
22. Giannakopoulos GF, Lubbers WD, Christiaans HM, van
Exter P, Bet P, Hugen PJ, et al. Cancellations of (helicopter-
transported) mobile medical team dispatches in the
Netherlands. Langenbecks Arch Surg. 2010;395(6):737–45.
doi:10.1007/s00423-009-0576-7.
23. Teasdale G, Jennett B. Assessment of coma and impaired
consciousness. A practical scale. Lancet. 1974;2(7872):81–4.
24. Ringdal KG, Coats TJ, Lefering R, Di Bartolomeo S, Steen
PA, Roise O, et al. The Utstein template for uniform report-
ing of data following major trauma: a joint revision by
SCANTEM, TARN, DGU-TR and RITG. Scand J Trauma
Resusc Emerg Med. 2008;16:7. doi:10.1186/1757-7241-16-7.
25. Castren M, Karlsten R, Lippert F, Christensen EF, Bovim E,
Kvam AM, et al. Recommended guidelines for reporting on
emergency medical dispatch when conducting research in
emergency medicine: the Utstein style. Resuscitation. 2008;
79(2):193–7. doi:10.1016/j.resuscitation.2008.07.007.
26. Marshall LF, Marshall SB, Klauber MR, Van Berkum Clark
M, Eisenberg H, Jane JA, et al. The diagnosis of head injury
requires a classification based on computed axial tomog-
raphy. Journal of Neurotrauma. 1992;9(Suppl 1):S287–S92.
27. Maas AI, Hukkelhoven CW, Marshall LF, Steyerberg EW.
Prediction of outcome in traumatic brain injury with com-
puted tomographic characteristics: a comparison between the
computed tomographic classification and combinations of
computed tomographic predictors. Neurosurgery. 2005;57(6):
1173–82; discussion-82. doi:10.1227/
01.NEU.0000186013.63046.6B.
28. Champion HR, Sacco WJ, Copes WS, Gann DS, Gennarelli
TA, Flanagan ME. A revision of the trauma score. J Trauma.
1989;29(5):623–9.
29. Gennarelli TA, Wodzin E, (editors). Abbreviated injury scale
2005 – update 2008. Des Plaines, IL: American Association
for Automotive Medicine (AAAM); 2008.
30. Baker SP, O'Neill B, Haddon W Jr, Long WB. The injury
severity score: a method for describing patients with mul-
tiple injuries and evaluating emergency care. J Trauma. 1974;
14(3):187–96. doi:10.1097/00005373-197403000-00001.
31. Jennett B, Bond M. Assessment of outcome after severe brain
damage. Lancet. 1975;1(7905):480–4.
32. Jennett B, Snoek J, Bond MR, Brooks N. Disability after
severe head injury: observations on the use of the Glasgow
outcome scale. J Neurol Neurosurg Psychiatry. 1981;44(4):
285–93.
33. Vetter TR, Schober P. Regression: the apple does not fall far
from the tree. Anesth Analg. 2018;127(1):277–83. doi:10.1213/
ANE.0000000000003424.
34. Schober P, Bossers SM, Schwarte LA. Statistical significance
versus clinical importance of observed effect sizes: what do
P values and confidence intervals really represent? Anesth
Analg. 2018;126(3):1068–72. doi:10.1213/
ANE.0000000000002798.
35. Bossers SM, Pol KM, Oude Ophuis EPA, Jacobs B, Visser
MC, Loer SA, et al. Discrepancy between the initial assess-
ment of injury severity and post hoc determination of injury
severity in patients with apparently mild traumatic brain
injury: a retrospective multicenter cohort analysis. Eur J
Trauma Emerg Surg. 2017;44(6): 889–896.
36. Reith FC, Van den Brande R, Synnot A, Gruen R, Maas AI.
The reliability of the Glasgow Coma scale: a systematic
review. Intensive Care Med. 2016;42(1):3–15. doi:10.1007/
s00134-015-4124-3.
37. Cnossen MC, van der Brande R, Lingsma HF, Polinder S,
Lecky F, Maas AIR. Prehospital Trauma Care among 68
European Neurotrauma Centers: results of the CENTER-TBI
provider profiling questionnaires. J Neurotrauma. 2018;36(1):
176–181.
8 PREHOSPITAL EMERGENCY CARE / 2019 VOLUME 0 / NUMBER 0
